Bio-Techne (TECH) Profit After Tax (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Profit After Tax of $51.0 million in Q1 2026, up 34.3% quarter-over-quarter from $38.0 million in Q4 2025, and up 125.99% on a YoY basis from $22.6 million in Q1 2025.
Bio-Techne (TECH) Profit After Tax (2009 - 2026) Analysis & Trends
Bio-Techne's Profit After Tax history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 125.99% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $109.6 million (down 16.79% YoY), while the FY2025 annual figure was $73.4 million, down 56.34% from the prior year.
- Profit After Tax was $51.0 million for Q1 2026 at Bio-Techne, up from $38.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $89.7 million in Q3 2022 to a low of -$17.7 million in Q2 2025.
- Historically, Profit After Tax has averaged $45.7 million across 5 years, with a median of $49.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax soared 338.03% in 2022, then tumbled 143.55% in 2025.
- A 5-year view of Profit After Tax shows it stood at $50.0 million in 2022, then sank by 45.08% to $27.5 million in 2023, then advanced by 27.03% to $34.9 million in 2024, then advanced by 8.94% to $38.0 million in 2025, then jumped by 34.3% to $51.0 million in 2026.
- The last three Profit After Tax figures came in at $51.0 million (Q1 2026), $38.0 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 51.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.05 Mn |
| Dec 31, 2025 | 38.01 Mn |
| Sep 30, 2025 | 38.19 Mn |
| Jun 30, 2025 | -17.68 Mn |
| Mar 31, 2025 | 22.59 Mn |
| Dec 31, 2024 | 34.89 Mn |
| Sep 30, 2024 | 33.60 Mn |
| Jun 30, 2024 | 40.59 Mn |
| Mar 31, 2024 | 49.06 Mn |
| Dec 31, 2023 | 27.47 Mn |
| Sep 30, 2023 | 50.99 Mn |
| Jun 30, 2023 | 75.31 Mn |
| Mar 31, 2023 | 70.22 Mn |
| Dec 31, 2022 | 50.01 Mn |
| Sep 30, 2022 | 89.73 Mn |
| Jun 30, 2022 | 61.92 Mn |
| Mar 31, 2022 | 60.74 Mn |
| Dec 31, 2021 | 72.06 Mn |
| Sep 30, 2021 | 68.98 Mn |
| Jun 30, 2021 | 14.14 Mn |